Safety of studies analysing clinical benefit of amygdalin

Immunopharmacol Immunotoxicol. 2014 Feb;36(1):87. doi: 10.3109/08923973.2013.861846. Epub 2014 Jan 8.
No abstract available

Publication types

  • Letter
  • Review

MeSH terms

  • Amygdalin / adverse effects
  • Amygdalin / therapeutic use*
  • Animals
  • Antineoplastic Agents, Phytogenic / adverse effects
  • Antineoplastic Agents, Phytogenic / therapeutic use*
  • Cyanides / poisoning*
  • Humans
  • Neoplasms / drug therapy*

Substances

  • Antineoplastic Agents, Phytogenic
  • Cyanides
  • Amygdalin